Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively. |
Targets&IC50 | FFA1/GPR40:(EC50)3.6 nM, FFA1/GPR40 (in CHO cells):36 nM(EC50) |
Molecular Weight | 488.48 |
Formula | C24H19F3N2O4S |
CAS No. | 1011531-27-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AM-4668 1011531-27-3 Endocrinology/Hormones GPCR/G Protein GPR AM 4668 AM4668 inhibitor inhibit